Indications & Uses
Luminor is indicated for:
Dosage Reference
Reference Information Only
Dosages shown are general references from official sources. Always consult your doctor or pharmacist for personalized dosing.
Adults:
0.2% ophthalmic solution: The recommended dose is one drop of 0.2% ophthalmic solution in the affected eye(s) three times daily, approximately 8 hours apart. This ophthalmic solution may be used concomitantly with other topical ophthalmic drug products to lower intraocular pressure. If more than one topical ophthalmic product is being used, the products should be administered at least 5 minutes apart.0.15% ophthalmic solution: The recommended dose is one drop of 0.15% ophthalmic solution in the affected eye(s) three times daily, approximately 8 hours apart.0.025% ophthalmic solution: Instill 1 drop in the affected eye(s) every 6-8 hours. Do not use it more than 4 times daily. If more than one topical ophthalmic product is being used, the products should be administered at least 5 minutes apart.
Side Effects
Adverse events occurred in about 10 to 30 percent of subjects, and in descending order of frequency included dryness of the mouth, redness of the eye, burning and stinging, headache, blurred vision, a sensation of something in the eye, fatigue or drowsiness, conjunctival follicles, ocular allergic reactions, and itching of the eye. Events occurring in about 3 to 9 percent of subjects, again in descending order, included corneal staining or erosion, sensitivity to light, redness of the eyelid, eye ache or pain, dryness of the eye, tearing, upper respiratory symptoms, eyelid swelling, conjunctival swelling, dizziness, blepharitis, eye irritation, gastrointestinal symptoms, weakness, blanching of the conjunctiva, abnormal vision, and muscular pain. The following reactions were reported in fewer than 3 percent of patients: crusting of the eyelid, bleeding beneath the conjunctiva, altered taste, insomnia, discharge from the eye, depression, high blood pressure, anxiety, palpitations or irregular heartbeat, dryness of the nose, and fainting.
Cautions & Contraindications
Warnings & Precautions
Although Brimodin ophthalmic solution had little effect on blood pressure in clinical studies, it should be used carefully in patients with severe cardiovascular disease. Caution is also advised when prescribing it for patients with depression, cerebral or coronary insufficiency, Raynaud's phenomenon, orthostatic hypotension, or thromboangiitis obliterans.
Contraindications
Brimonidine Tartrate ophthalmic solution should not be used by anyone who is hypersensitive to Brimonidine Tartrate. It should also be avoided in patients currently on monoamine oxidase (MAO) inhibitor therapy.